Ionis Pharmaceuticals Gains FDA Approval for New Drug to Treat Rare Genetic Disorder
The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals (NASDAQ: IONS) drug to treat a rare genetic disorder, making […]
Ionis Pharmaceuticals Gains FDA Approval for New Drug to Treat Rare Genetic Disorder Read More »
